Cayetano Heredia University is a private nonprofit university located in Lima, Peru. It was named in honor of Cayetano Heredia, one of the eminent Peruvian physicians of the 19th century. The university is overseen by a board of trustees and is not owned by any private or state entity.

During the past decade, Universidad Peruana Cayetano Heredia conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universidad Peruana Cayetano Heredia" #1 sponsor was "Universidad Peruana Cayetano Heredia" with 6 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials sponsored, "Istituto Auxologico Italiano" with 2 trials sponsored, "Drugs for Neglected Diseases" with 1 trials sponsored and "Duke University" with 1 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universidad Peruana Cayetano Heredia" #1 collaborator was "Universidad Peruana Cayetano Heredia" with 8 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 3 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator, "Asociacion Benefica Prisma" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 46 trials.

According to Clinical.Site data, the most researched conditions in "Universidad Peruana Cayetano Heredia" are "HIV Infections" (4 trials), "Hypertension" (4 trials), "HIV" (2 trials), "Leishmaniasis, Cutaneous" (2 trials) and "Adherence" (1 trials). Many other conditions were trialed in "Universidad Peruana Cayetano Heredia" in a lesser frequency.

Most popular intervention types in "Universidad Peruana Cayetano Heredia" are "Behavioral" (8 trials), "Drug" (7 trials), "Device" (4 trials), "Other" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Albendazole" (2 trials), "ABZ Placebo" (1 trials), "Afini App" (1 trials), "CL Detect™ Rapid Test" (1 trials) and "CONEMO" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universidad Peruana Cayetano Heredia" are 26 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Universidad Peruana Cayetano Heredia". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Universidad Peruana Cayetano Heredia, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Universidad Peruana Cayetano Heredia, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 12 trials that are defined as “Not Applicable".